Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Updated on: July 05,2024

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Updated on:July 05,2024

Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases

JANUARY 31, 2024byCNRSIllustration of the invasive capacity of breast cancer cells with (on) and without (off) SMYD2 expression; Scale bar: 10µm. Credit: Casanova et al.A protein found abundantl

Updated on: March 25,2024

Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases

JANUARY 31, 2024byCNRSIllustration of the invasive capacity of breast cancer cells with (on) and without (off) SMYD2 expression; Scale bar: 10µm. Credit: Casanova et al.A protein found abundantl

Updated on:March 25,2024

New liquid biopsy test to ID lymph node metastasis in early-stage T1 colorectal cancer

by City of Hope National Medical CenterCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Scientists at City of Hope, a world-renowned independent research and treat

Updated on: April 29,2024

New liquid biopsy test to ID lymph node metastasis in early-stage T1 colorectal cancer

by City of Hope National Medical CenterCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Scientists at City of Hope, a world-renowned independent research and treat

Updated on:April 29,2024

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Updated on: April 20,2024

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Updated on:April 20,2024

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Updated on: January 28,2024

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Updated on:January 28,2024

Study points to practice-changing care for patients with refractory metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainJosep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase

Updated on: February 23,2024

Study points to practice-changing care for patients with refractory metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainJosep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase

Updated on:February 23,2024

Incidence of Hodgkin lymphoma up in least deprived areas

Individuals living in the most affluent areas of the United Kingdom seem to have an increased incidence of Hodgkin lymphoma (HL), according to a study published in the August issue ofBMJ Open.Me

Updated on: March 21,2024

Incidence of Hodgkin lymphoma up in least deprived areas

Individuals living in the most affluent areas of the United Kingdom seem to have an increased incidence of Hodgkin lymphoma (HL), according to a study published in the August issue ofBMJ Open.Me

Updated on:March 21,2024

AI-based app can help physicians find skin melanoma

by Karin Söderlund,Swedish Research CouncilGraph showing the relationships between the primary care physicians' (PCPs') reported degree of melanoma suspicion, final tumor diagnosis and t

Updated on: March 30,2024

AI-based app can help physicians find skin melanoma

by Karin Söderlund,Swedish Research CouncilGraph showing the relationships between the primary care physicians' (PCPs') reported degree of melanoma suspicion, final tumor diagnosis and t

Updated on:March 30,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on: February 24,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on:February 24,2024

Cancer cells can reuse apparent 'dead end metabolites'

by Quinn Eastman,Emory UniversityThe oxidative pentose phosphate pathway gives cancer cells both cellular building blocks for rapid growth and a critical internal antioxidant called NADPH. 6-pho

Updated on: March 08,2024

Cancer cells can reuse apparent 'dead end metabolites'

by Quinn Eastman,Emory UniversityThe oxidative pentose phosphate pathway gives cancer cells both cellular building blocks for rapid growth and a critical internal antioxidant called NADPH. 6-pho

Updated on:March 08,2024

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Updated on: March 25,2024

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Updated on:March 25,2024

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Updated on: December 28,2023

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Updated on:December 28,2023